Company
Agios Pharmaceuticals
Also known as Agios Pharmaceuticals, Inc
- Business model
- B2B
- Legal name
- Agios Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. This foundation will remain constant at Agios and accelerate our impact moving forward.
Funding snapshot
- Total raised
- $86.8MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $78M2011-11-16
Funding rounds
- Round, 2011
- $78M2011-11-16, SEC form D sold, 19 investors
- Round, 2010
- $8.8M2010-04-14, SEC form D sold, 1 investor
Loading relationship preview